A healthcare procurement manager explains why total cost beats sticker price for ConvaTec, ConvaTec Me Plus, patient monitors, autoclave machines, and CPAP devices.

I'll state the opinion that made me unpopular in a budget meeting: the lowest-priced medical supply is usually the most expensive purchase order I can sign. Five years ago, I wouldn't have said that. I was a procurement coordinator who compared quotes, chose the lower number, and called it a win. Then I started tracking what happened after the invoice was paid, and my old spreadsheet was lying to me.

What changed wasn't one dramatic product failure. It was a slow pattern. When I audited our 2023 spending, I reviewed 1,847 order lines across wound care, ostomy, continence, infusion, and capital equipment. My team had saved about $63,000 by shifting to lower-cost vendors. Nearly $7,000 of that vanished through expedited freight, returns, replacement orders, and clinical time spent fixing problems. I might be misremembering a decimal here or there, but the direction was clear: total cost was not following unit cost.

In other words, the industry has changed. Best practice in 2018 was to award the business to the lowest responsive quote and move on. In 2025, that approach is not enough. The fundamentals of procurement are the same—clear specs, fair competition, reliable suppliers—but the execution needs to include failure rates, support, and training. Saying a product is the same is no longer a claim I can accept from a spec sheet alone.

ConvaTec Taught Me That Price Tags Don't Show Total Cost

ConvaTec is one product family that changed how I build my cost models. According to ConvaTec's website (convatec.com), the portfolio covers wound, ostomy, continence, and infusion care. That breadth matters in procurement, but the product details matter more.

A good example is moldable skin barrier technology. I'm not a clinician, so I can't speak to which barrier is clinically best. What I can tell you from a procurement perspective is that the invoice price does not capture what happens at the bedside. If a barrier needs to be cut, adjusted, re-applied, or explained carefully by a nurse, the labor and follow-up costs are real even if they occur after the product is used.

I also underrated the supporting materials in the early years. When ConvaTec Me Plus resources came in the same shipment as the products, I almost wrote them off as marketing. That was a mistake. I don't have hard national data, but based on the facilities we track, the ones that actually used education resources had fewer urgent reorder calls and fewer 'we tried this and it didn't work' conversations. At least, that's been my experience, and it's why I now include support utilization in my cost reviews.

Then there is the logo issue. I used to think the ConvaTec logo on a box was enough. Now I treat it as the beginning of a verification process. We once received a below-market quote from an unauthorized reseller for an item that carried a ConvaTec logo. The box looked right, but the lot numbers could not be traced to an authorized distributor. I declined the order. Perhaps I was overcareful. Given what a broken supply chain can cost, I'll accept that risk every time.

Patient Monitors and Autoclave Machines Follow the Same Rule

The same total cost logic applies outside chronic care. A patient monitor is a classic example. The purchase price is easy to compare; the real cost is hidden in ECG cables, SpO2 sensors, service contracts, software upgrades, and replacement parts. I have compared two patient monitors where one looked cheaper by $1,200 until I added the expected five-year service costs. The cheaper monitor no longer looked cheap.

An autoclave machine makes the point in even blunter language. An autoclave machine uses pressurized steam to sterilize instruments, but the machine purchase is only a fraction of the operating cost. Biological indicators, cycle documentation, routine maintenance, failed loads, and downtime all count. If lower-priced equipment means slower cycles or longer service lead times, the savings disappear quickly.

Even the CPAP Question Is a Cost Question

Someone always asks me how does a CPAP machine work? Actually, a nurse manager asked me that last year, and the answer is simple. A CPAP machine moves room air through a filter and delivers it at continuous positive airway pressure to keep the upper airway open during sleep. The harder question is not how does a CPAP machine work; it is what does the CPAP machine cost over the first year. Masks, tubing, filters, humidifier chambers, teaching time, and early follow-up visits matter. A cheaper CPAP machine with poor mask fit is not cheaper.

The Objection I Keep Hearing

By now someone will say that I am protecting higher prices and ignoring legitimate savings. That is not true. I approve cheaper options when the evidence supports them. My issue is treating 'same' as an assumption rather than a verification.

Here's what I check before accepting an alternative:

• Authorized distribution and lot traceability from manufacturer to shelf.
• Return, recall, and complaint processes that do not put extra work on clinical staff.
• Support materials and training, like the ConvaTec Me Plus resources, that affect how the product is used.
• Contract terms that allow me to see the total cost after failures, not only the price at the time of order.

What I Buy Now

I stopped asking which supplier has the lowest price. I now ask which supplier has the lowest total cost. The question sounds like a small shift, but it changes the spreadsheet. The ConvaTec logo, the Me Plus education folder, the patient monitor service plan, the autoclave machine's cycle reliability, and the CPAP machine's fit all belong in the same column: cost after purchase.

The industry has moved beyond the era when a rubber stamp and lowest quote were enough. The fundamentals of budgeting haven't changed, but the way we account for product success has to change with it. Price is the start. It should never be the ending.